Lonza to acquire Sterile Fill and Finish Facility from Novartis
BASEL, SWITZERLAND: Lonza Pharma & Biotech has announced its entry into a binding contractual commitment for the purchase of a sterile drug product fill & finish facility from Novartis. The…